Literature DB >> 487644

Inhibition of neutrophil migration by sera from patients with rheumatoid arthritis.

A S Kemp, P Roberts-Thomson, S H Neoh, S Brown.   

Abstract

Sera from patients with rheumatoid arthritis inhibited the migration of human neutrophils in 63% (twenty-two out of thirty-five) of the cases tested. The inhibition was not due to a toxic effect of the serum as it was reversed by a chemotactic stimulus. There was a strong correlation between the degree of inhibition of neutrophil migration and the amount of immune complexes present in the sera as determined by the C1q binding activity. It is suggested that the inhibition of neutrophil migration is due to the presence of circulating immune complexes, and that the capacity of immune complexes to inhibit neutrophil migration in vitro may also contribute to the accumulation of neutrophils at sites of immune complex formation in vivo.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 487644      PMCID: PMC1537753     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Presence of aggregated gamma-G-globulin in certain rheumatoid synovial effusions.

Authors:  K Hannestad
Journal:  Clin Exp Immunol       Date:  1967-07       Impact factor: 4.330

2.  The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.

Authors:  T Wagner; G Abraham; J Baum
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

3.  Effector activating determinants on IgG. I. The distribution and factors influencing the display of complement, neutrophil and cytotoxic B-cell determinants on human IgG sub-classes.

Authors:  I C MacLennan; A Howard; F M Gotch; P G Quie
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

4.  Serum gold. II. Levels in rheumatoid arthritis.

Authors:  H M Rubinstein; A A Dietz
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

5.  The release of granule enzymes from human neutrophils stimulated by aggregated immunoglobulins of different classes and subclasses.

Authors:  P M Henson; H B Johnson; H L Spiegelberg
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

6.  Stimulation of human neutrophils by soluble and insoluble immunoglobulin aggregates. Secretion of granule constituents and increased oxidation of glucose.

Authors:  P M Henson; Z G Oades
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

7.  Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole.

Authors:  A G Mowat
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

8.  Immunoglobulin phagocytosis by granulocytes from sera and synovial fluids in various rheumatoid and nonrheumatoid diseases.

Authors:  A Cats; G J Lafeber; F Klein
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

9.  Phagocytic function of polymorphonuclear leukocytes in rheumatic diseases.

Authors:  R A Turner; R Schumacher; A R Myers
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

10.  Inhibition of human neutrophil migration by aggregated gammaglobulin.

Authors:  A Kemp; P Roberts-Thomson; S Brown
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

View more
  10 in total

1.  Polymorphonuclear leucocyte motility in men with ankylosing spondylitis.

Authors:  C T Pease; M Fennell; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

2.  Changes in normal polymorphonuclear leucocyte motility after ingestion of IgG aggregates.

Authors:  D H Goddard; A P Kirk; K A Brown; D McCarthy; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

3.  Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent.

Authors:  J Elmgreen; T M Hansen
Journal:  Ann Rheum Dis       Date:  1985-08       Impact factor: 19.103

4.  Abnormalities of neutrophil function do not cause the migration defect in Crohn's disease.

Authors:  C O Moráin; A A Segal; D Walker; A J Levi
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

5.  Polymorphonuclear cell function in rheumatoid arthritis and in Felty's syndrome.

Authors:  G B Howe; J N Fordham; K A Brown; H L Currey
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

6.  A comparison of leukocyte aggregation, leukocyte migration and skin reactivity to recall antigens in patients with AIDS.

Authors:  B Rouveix; F Groult; J J Pocidalo
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

7.  Evaluation of cellular immune response during chronic schistosomiasis in humans by the leukocyte aggregation test and the leukocyte migration inhibition test.

Authors:  B Rouveix; F Derouin; M Levacher
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

8.  The effect of salicylate on human leucocyte migration.

Authors:  A S Kemp; J Smith
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

9.  Neutrophil functions and clinical performance after total fasting in patients with rheumatoid arthritis.

Authors:  A M Udén; L Trang; N Venizelos; J Palmblad
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

10.  Migration of blood and synovial fluid neutrophils obtained from patients with rheumatoid arthritis.

Authors:  A S Kemp; S Brown; P M Brooks; S H Neoh
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.